Artificial intelligence is driving pharma’s R&D’s digital transformation and data is what fuels it. At Elsevier, we enable evidence-based decision-making and improved productivity through our unique expertise in curating, enriching, integrating, and harmonizing scientific data assets. These data assets are delivered as workflow tools or as unique datasets to which analytics can be applied. As a result, our customers can better predict outcomes, mitigate risk, and reveal novel discoveries based upon new connections in the data. Elsevier’s acquisition of SciBite (a data-first scientific software company) means that we now have access to more tools for enabling FAIR standards (such as ontologies, text analytics and semantic search) and for helping researchers find, share, and organize information.